No headlines found.
Forian Inc. Announces Third Quarter 2024 Financial Results
Globe Newswire (Wed, 13-Nov 4:00 PM ET)
Forian Inc. to Participate in the 13th Annual ROTH MKM Technology Event
Globe Newswire (Fri, 8-Nov 3:59 PM ET)
Forian Inc. to Announce Third Quarter 2024 Results on November 13, 2024
Globe Newswire (Tue, 5-Nov 1:00 PM ET)
Forian Acquires Kyber Data Science to Enhance Data Analytics Capabilities
Globe Newswire (Fri, 1-Nov 9:00 AM ET)
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
Forian trades on the NASDAQ stock market under the symbol FORA.
As of December 11, 2024, FORA stock price declined to $2.05 with 5,394 million shares trading.
FORA has a market cap of $63.58 million. This is considered a Micro Cap stock.
Last quarter Forian reported $5 million in Revenue and -$.01 earnings per share. This fell short of revenue expectation by $-124,000 and exceeded earnings estimates by $.02.
In the last 3 years, FORA traded as high as $9.43 and as low as $1.85.
The top ETF exchange traded funds that FORA belongs to (by Net Assets): VTI, VXF, IWC, DFAC, DFSU.
FORA has underperformed the market in the last year with a price return of -15.5% while the SPY ETF gained +33.6%. FORA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.1% and -0.5%, respectively, while the SPY returned +11.1% and +1.2%, respectively.
FORA support price is $1.98 and resistance is $2.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FORA shares will trade within this expected range on the day.